Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

VOR

Vor Biopharma Inc

Jun 25 • 04:00PM ET

1.24

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO CNCR IWC VTWV RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	12.87%	Shs Outstand	67.89M	Perf Week	5.98%
Market Cap	84.64M	Forward P/E	-	EPS next Y	-1.37	Insider Trans	-0.17%	Shs Float	59.48M	Perf Month	-22.98%
Income	-120.23M	PEG	-	EPS next Q	-0.42	Inst Own	42.30%	Short Float	6.01%	Perf Quarter	-39.22%
Sales	0.00M	P/S	-	EPS this Y	8.19%	Inst Trans	1.19%	Short Ratio	12.49	Perf Half Y	-42.33%
Book/sh	1.80	P/B	0.69	EPS next Y	14.73%	ROA	-54.09%	Short Interest	3.57M	Perf Year	-71.23%
Cash/sh	1.57	P/C	0.79	EPS next 5Y	-	ROE	-68.07%	52W Range	1.11 - 4.30	Perf YTD	-44.89%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-73.43%	ROI	-78.17%	52W High	-71.16%	Beta	-0.30
Dividend TTM	-	Quick Ratio	8.46	Sales past 5Y	0.00%	Gross Margin	-	52W Low	11.71%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	8.46	EPS Y/Y TTM	17.22%	Oper. Margin	0.00%	RSI (14)	37.83	Volatility	5.79% 8.07%
Employees	168	Debt/Eq	0.28	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.25	Target Price	14.06
Option/Short	Yes / Yes	LT Debt/Eq	0.25	EPS Q/Q	-5.52%	Payout	-	Rel Volume	2.50	Prev Close	1.24
Sales Surprise	-	EPS Surprise	-19.11%	Sales Q/Q	-	Earnings	May 09 AMC	Avg Volume	286.20K	Price	1.24
SMA20	-4.15%	SMA50	-20.94%	SMA200	-38.04%	Trades		Volume	716,528	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-22	Initiated	Wedbush	Outperform	$18
Apr-27-22	Initiated	Goldman	Neutral	$6
Dec-17-21	Initiated	H.C. Wainwright	Buy	$26
Dec-03-21	Initiated	Robert W. Baird	Outperform	$38
Dec-02-21	Initiated	Oppenheimer	Outperform	$30
Oct-19-21	Initiated	JMP Securities	Mkt Outperform	$40
Mar-25-21	Initiated	B. Riley Securities	Buy	$60
Mar-03-21	Initiated	Evercore ISI	Outperform	$48
Mar-03-21	Initiated	Barclays	Overweight	$56
Mar-02-21	Initiated	Stifel	Buy	$58
Mar-02-21	Initiated	Goldman	Sell	$19

Show Previous Ratings

Jun-04-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.69%
May-13-24 09:22AM	Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating (MT Newswires)
May-09-24 10:54PM	VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024 (InvestorPlace) -5.52%
04:05PM	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
May-06-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:01PM	Loading…
May-03-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-02-24 04:01PM	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors (GlobeNewswire)
Apr-04-24 08:32AM	Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock (Zacks)
Apr-01-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.17%
Mar-20-24 09:53PM	VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 (InvestorPlace) +8.89%
04:05PM	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update (GlobeNewswire)
Mar-05-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-04-24 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-15-24 02:56PM	2 Strong Buy Penny Stocks That Could Rally All the Way to $10 (or More) (TipRanks)
Feb-07-24 08:00AM	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
04:01PM	Loading…
Feb-02-24 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.53%
Jan-19-24 08:22AM	Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study (Zacks) -8.30%
Jan-17-24 04:01PM	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update (GlobeNewswire) +7.39%
Dec-21-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.11% -8.37%
Dec-01-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.98%
Nov-27-23 08:00AM	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit (GlobeNewswire)
Nov-09-23 04:01PM	Vor Bio Presents Positive Data Update on Trem-cel at HSCT Conference (GlobeNewswire) -5.38%
Nov-07-23 04:05PM	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire) +9.34% -6.53%
Nov-03-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.43%
08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 09:01AM	Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio's Novel eHSC and CAR-T Platform (GlobeNewswire) +5.74%
Oct-03-23 04:01PM	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Sep-25-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-30-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 04:05PM	Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire) +14.40%
08:00AM	Loading…
Aug-01-23 08:00AM	Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jun-09-23 04:03PM	Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients (Benzinga) -6.19%
07:30AM	Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bios Platform (GlobeNewswire)
Jun-05-23 08:00AM	Vor Bio to Participate in the Goldman Sachs Healthcare Conference (GlobeNewswire)
May-11-23 04:05PM	Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire)
Apr-19-23 02:42PM	We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth (Simply Wall St.)
Apr-18-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.82%
Mar-28-23 09:55AM	How Much Upside is Left in Vor Biopharma Inc. (VOR)? Wall Street Analysts Think 172.06% (Zacks)
Mar-23-23 04:01PM	Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update (GlobeNewswire) -6.08% +15.29%
Mar-07-23 05:52AM	Vor Biopharma Inc. (NASDAQ:VOR) Shares Could Be 43% Below Their Intrinsic Value Estimate (Simply Wall St.)
Feb-21-23 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 02:04PM	Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant (Benzinga) -6.47%
12:00PM	First AML Patient Transplanted with Vor Bios Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg Cycles at Initial Dose Level (GlobeNewswire)
Jan-19-23 08:00AM	Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings (GlobeNewswire)
Jan-12-23 08:00AM	Vor Bio to Present at B. Riley Securities 3rd Annual Oncology Conference (GlobeNewswire)
Dec-16-22 06:40PM	Bath & Body Works and Vor Biopharma Stock See Action From Activist Investors (Barrons.com) -11.17%
Dec-07-22 07:45AM	Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million (GlobeNewswire) +41.86%
07:30AM	First AML Patient Successfully Transplanted with Vor Bios Investigational Trem-cel (VOR33) and Tolerated Mylotarg (GlobeNewswire)
Nov-30-22 10:35AM	2 Strong Buy Penny Stocks That Could Rally All the Way to $15 (TipRanks) +6.48%
Nov-22-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-10-22 04:15PM	Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire) +5.03%
Nov-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-14-22 10:26AM	Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely? (Simply Wall St.)
Oct-12-22 08:00AM	Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer (GlobeNewswire)
Oct-11-22 08:00AM	Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment (GlobeNewswire)
Sep-28-22 08:00AM	Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters (GlobeNewswire)
Sep-06-22 04:15PM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-01-22 09:55AM	Can Vor Biopharma Inc. (VOR) Climb 298% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-16-22 09:55AM	How Much Upside is Left in Vor Biopharma Inc. (VOR)? Wall Street Analysts Think 295% (Zacks)
Aug-11-22 04:15PM	Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire) +8.43%
Aug-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.64%
Jun-10-22 08:00AM	Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA (GlobeNewswire)
Jun-01-22 08:00AM	Vor Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-22 04:15PM	Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire)
May-07-22 09:20AM	We Think Vor Biopharma (NASDAQ:VOR) Can Afford To Drive Business Growth (Simply Wall St.)
May-05-22 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Apr-25-22 08:00AM	Vor Bio to Present at Keystone Symposia Precision Genome Engineering Meeting (GlobeNewswire)
Apr-14-22 04:15PM	Vor Bio Announces Retirement of Chief Medical Officer (GlobeNewswire) +8.74%
Mar-22-22 10:10AM	Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases (Business Wire) +6.16%
Mar-14-22 04:30PM	Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update (GlobeNewswire) -9.52%
Feb-28-22 08:00AM	Vor to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Feb-11-22 08:00AM	Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire) -7.03%
Jan-04-22 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Nov-29-21 08:00AM	Vor to Participate in the JMP Securities Hematology and Oncology Summit (GlobeNewswire)
Nov-25-21 07:35AM	15 Pharmaceutical Stocks to Buy According to Peter Kolchinskys RA Capital (Insider Monkey)
Nov-19-21 04:01PM	Vor to Participate in Piper Sandler 33rd Virtual Annual Healthcare Conference (GlobeNewswire) -8.17%
11:48AM	Vor Biopharma Insider Sold Over $5.0M In Company Stock (Benzinga)
Nov-15-21 10:39AM	Does Vor Biopharma (VOR) Have the Potential to Rally 186% as Wall Street Analysts Expect? (Zacks)
Nov-11-21 12:51PM	We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash Wisely (Simply Wall St.)
Nov-10-21 04:10PM	Vor Reports Third Quarter 2021 Financial Results and Provides Company Update (GlobeNewswire) -6.20%
Nov-09-21 08:30AM	Vor to Present New Data on its Cell and Genome Engineering Platform at SITC Annual Meeting (GlobeNewswire) -5.16%
Nov-08-21 08:00AM	Vor to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Nov-04-21 09:15AM	Vor to Present New Platform and Preclinical Data at ASH (GlobeNewswire)
Oct-19-21 07:00AM	Vor to Present Data from its Novel Cell and Genome Engineering Platform at ESGCT (GlobeNewswire) +8.27%
Oct-12-21 08:00AM	Vor Strengthens Leadership Team with Addition of Dr. Veit Schmelmer as SVP of Program and Alliance Management (GlobeNewswire)
Sep-09-21 08:00AM	VOR33 Granted U.S. FDA Fast Track Designation for AML (GlobeNewswire)
Sep-02-21 08:00AM	Vor to Participate in Three Upcoming Investor Conferences (GlobeNewswire) +9.51%
Aug-09-21 04:05PM	Vor Reports Second Quarter 2021 Financial Results and Provides Company Update (GlobeNewswire) -7.17%
Jul-08-21 08:00AM	Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) (GlobeNewswire) +9.04%
Jun-17-21 08:00AM	Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs (GlobeNewswire)
Jun-11-21 08:00AM	Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp (GlobeNewswire)
Jun-10-21 08:00AM	Vor to Develop Multi-Targeted CAR-Ts with Abound Bio (GlobeNewswire) +6.76%
May-25-21 04:10PM	Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences (GlobeNewswire) +6.00%
May-07-21 10:30AM	How Many Vor Biopharma Inc. (NASDAQ:VOR) Shares Do Institutions Own? (Simply Wall St.)
May-06-21 04:08PM	Vor Reports First Quarter 2021 Financial Results and Provides Company Update (GlobeNewswire) -12.02%
Apr-28-21 08:00AM	Vor To Present on VOR33 Manufacturing Scale-Up and Off-Target Editing at ASGCT (GlobeNewswire)
Mar-25-21 04:35PM	Vor Reports Fiscal Year 2020 Financial Results (GlobeNewswire) -6.49%
Mar-05-21 03:00PM	Vor Biopharma to Present at the Barclays Global Healthcare Conference (GlobeNewswire)
Mar-01-21 03:45PM	Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference (GlobeNewswire) +6.76%
Feb-09-21 04:05PM	Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Attar Eyal C.	CHIEF MEDICAL OFFICER	Jun 03 '24	Sale	1.39	14,645	20,357	96,063	Jun 04 06:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VOR

Vor Biopharma Inc

Upgrade your FINVIZ experience